ARCHIVES

NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner.

This article is from The Cancer Letter archive.

Vol. 32 No. 21 | June 2, 2006

Download PDF Visit The Full Archive

Related Articles

Deals & Collaborations: UAB To Evaluate Firm’s Prostate Cancer Treatment

June 1, 2001

Interview: A Conversation with Robert Carlson

October 5, 2012

Winship to Open Glenn Family Breast Center

February 7, 2013

Potti Claimed Rhodes Credential in Bio Submitted for DOD Funding

July 30, 2010

No Cancer Letter for Two Weeks

August 13, 1993

Report Urges Changes To Cut Activation Times For NCI Phase III Trials.

April 9, 2010